Replies to post #13818 on Calmare Therapeutics Inc (fka CTTC)

[mog1962]

why do you never address any of the other issues, concerns or comments on this board.

You continue to remain a one-trick pony always touting studies that, as his pointed out, never seem to make it into the world or scientific publications to the extent they make any difference.

You also just keep pointing out that opiod addiction is a major problem but, despite what you thought might happen with the new President, it is clear that TrumpCare will reduce funding via Medicaid reductions for addiction treatments and probably reduce coverage from insurers, as well

How about comments about the company, the CEO, or the Board? It appears you have links to all of them and cannot act as anything but a shill. Too bad because it destroys your credibility

[Munchqin]

That is even more funny! Clinical studies publish the primary outcome/endpoint as and when it is available (because that matters the most) without waiting for the completion of secondary outcome/endpoint. Something fishy!! - Think, if the primary outcome is unfavorable who cares for the favorable or unfavorable secondary outcome/endpoint.
And right 5 months is not a long wait, and who knows the August 2017 update will move the date to August 2018??
This company started Calmare business in 2005, and 12 years down the road is still at ground zero, and some folks still believe it isn't a long wait!!!!!!! :)

[nobodysbusiness]

A pretty thorough review of research up until a year ago:

https://www.myoptumhealthphysicalhealth.com/ClinicalPolicies/485.pdf

Looks like whatever is upcoming will need to meet some pretty high standards to convince the insurer.